Dr. Alexander Taghva Introduces Focused Ultrasound Treatment for Essential Tremors in Orange County, CA

December 3, 2024 8:00 AM

Dr. Alexander Taghva is pleased to introduce focused ultrasound for treating tremors, now available in Orange County, CA. This innovative procedure offers a safe and effective option for patients with essential tremor, utilizing magnetic resonance imaging to guide high-intensity focused ultrasound energy. The procedure significantly improves tremor symptoms and functional disability, with most patients experiencing only mild side effects. As a...

Read more

NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders

December 3, 2024 7:40 AM

ZÜRICH, SWITZERLAND / ACCESSWIRE / December 3, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) (NLS), a biopharmaceutical company, is pleased to share preclinical data demonstrating the potential of its dual orexin receptor agonist (DOXA) platform. AEX-41 and AEX-2, two first-in-class non-sulfonamide DOXAs, are designed to target both orexin-1 (OX1R) and orexin-2 (OX2R) receptors while concurrently inhibiting cathepsins. Cathepsins...

Read more

Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1

December 3, 2024 7:30 AM

MIAMI, FL / ACCESSWIRE / December 3, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced groundbreaking preclinical results confirming the efficacy of its licensed molecule Telomir-1 in reversing several key parameters of Type 2 diabetes mellitus.The study demonstrated significant reductions in fasting plasma glucose levels to basal levels, improvements in...

Read more

Africa's Healthcare IT Sector Transformation: Black Book Research Spotlights Leading Advisory Firms Driving Digital Health Innovation

December 3, 2024 7:00 AM

Select nations in Africa are emerging as pioneers in digital health innovation, showcasing remarkable progress in transforming their healthcare systems through technology. With the continent's digital health market projected to grow from USD 6.1 billion in 2024 to USD 15.5 billion by 2030-achieving a robust compound annual growth rate (CAGR) of 14.8%-as South Africa, Kenya, Nigeria, Egypt, and Morocco are leading the way in leveraging technology...

Read more

Computed Tomography (CT) Market Set for Significant Growth, projected to Reach USD 7566.1 Million by 2034 at a 3.8% of CAGR Driven by Advances in Detector Technology and Image Reconstruction Algorithms | Future Market Insights, Inc.

December 3, 2024 7:00 AM

The Computed Tomography (CT) Market, valued at USD 5,210.7 million in 2024, is projected to grow steadily to USD 7,566.1 million by 2034, registering a compound annual growth rate (CAGR) of 3.8% over the forecast period. This growth is attributed to advancements in imaging technology, increasing adoption in healthcare, and a rise in diagnostic procedures globally.Growing geriatric populations, coupled with the rise in chronic diseases such as...

Read more

The Bioz AI Engine Enhances SEO for Research Product Suppliers and Distributors

December 3, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / December 3, 2024 / Bioz, Inc, a trailblazer in AI-enhanced research productivity solutions, continues to redefine how scientists select and validate research products with cutting-edge tools that also deliver significant SEO benefits to suppliers. By integrating Bioz Stars Ratings, Bioz Badges, and Bioz Content Hubs, suppliers can enhance their product visibility and validation, increase time-on-page, and drive...

Read more

Increasing advancements in healthcare sector are expected to continue boosting the Laboratory Information System Market | Future Market Insights, Inc.

December 3, 2024 3:00 AM

The global laboratory information system market is on a dynamic growth trajectory, projected to achieve a valuation of USD 2,166.3 million by the end of 2024, marking an impressive year-over-year growth of 6.0%. The market is set to maintain its momentum with a robust compound annual growth rate (CAGR) of 5.3% over the next decade, reaching an estimated USD 3,620.3 million by 2034.Cloud-Based Systems: Transforming Laboratory Management:Among...

Read more

NHI Announces Appointment of Candice Todd to the Board of Directors

December 2, 2024 4:15 PM

National Health Investors, Inc. (NYSE:NHI) announced today that Candice Todd will join the NHI Board of Directors effective January 1, 2025.Ms. Todd served as Managing Director/Global Chief Financial Officer of Morgan Stanley Real Estate Investments from 2019 until her retirement in February 2023. Ms. Todd first joined a predecessor of Morgan Stanley in 1994 and served in a variety of real estate investment, finance and accounting roles,...

Read more

Redefining Pet Care in 2025: How the Vets and BetterVet Merger is Shaping the Future of At-Home Veterinary Services

December 2, 2024 3:00 PM

The landscape of pet care is evolving rapidly, driven by increasing pet ownership and a demand for more convenient, personalized services. The recent merger between The Vets and BetterVet, two of the largest at-home veterinary providers, marks a significant milestone in this transformation. Together, they are set to redefine how veterinary care is delivered, offering a more accessible, tech-driven experience."With this merger, we're not just...

Read more

Allstar Health Brands, Inc. (ALST) Engages in Strategic Acquisition Negotiations with MergersCorp Investment Banking for Italian Soccer Team

December 2, 2024 1:30 PM

All Star Health Brands is pleased to announce that it is entering the final stages of negotiations for the acquisition of a soccer team located in northern Italy, which has most recently competed in Serie D. This team boasts a dedicated stadium and an extensive youth development program, aligning with our strategic objectives to build international partnerships and foster youth engagement in both Canada and the United States.The transaction has...

Read more

Jaguar Health Participating in December 3-5 Pet Connect Conference with Goal of Identifying Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs

December 2, 2024 10:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar"), under its Jaguar Animal Health tradename for the veterinary market, today issued a reminder that company personnel are attending the Pet Connect conference, taking place December 3-5, 2024 in Los Angeles, and are available for partnership discussions at the event. Jaguar is seeking a partner to fund and execute the development and commercialization of NP300, the company's prescription drug candidate...

Read more

Ascelia Pharma Presents Orviglance SPARKLE Study Primary Results as Cutting-Edge Research at the 2024 RSNA Annual Meeting

December 2, 2024 10:00 AM

MALMÖ, SE / ACCESSWIRE / December 2, 2024 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker: ACE) today presents the primary results from the Orviglance® phase 3 SPARKLE Study as an oral presentation at the world's largest radiology conference, RSNA, in Chicago.As communicated earlier, in the successful SPARKLE study, Orviglance significantly improved the visualization of focal liver lesions compared to unenhanced MRI in patients with...

Read more

Latin America’s Healthcare IT Market Surges: Black Book Highlights $10.2 Billion Growth Opportunity and Top Consulting Firms Leading Digital Transformation

December 2, 2024 10:00 AM

Latin America's healthcare technology sector is entering a period of unprecedented growth, with the market expected to more than double from $4.8 billion in 2024 to $10.2 billion by 2028. Driven by a 20.1% compound annual growth rate (CAGR), this boom presents transformative opportunities for healthcare IT consultants and implementation specialists to revolutionize care delivery across the region. Building on a decade of in-depth research across...

Read more

Scholarship Supporting Nursing Students Opens for the 2025-2026 Academic Year

December 2, 2024 9:00 AM

Fusion's Compassion in Care Scholarship is Now Accepting Applications, Supporting the Nation's Future Nurses as They Attend Nursing SchoolOMAHA, NE / ACCESSWIRE / December 2, 2024 / Omaha-based healthcare company Fusion has opened applications for the Compassion in Care Scholarship, a program created to support undergraduate nursing students and encourage the pursuit of nursing professions.Fusion's Compassion in Care Scholarship "The nation is...

Read more

Simulab Corporation Names Stephen Hertz as Chief Commercial Officer

December 2, 2024 9:00 AM

Simulab Corporation has appointed Stephen Hertz as its Chief Commercial Officer (CCO), effective immediately. Hertz will lead all sales and marketing functions and advance the company's mission to improve medical simulation training worldwide."We are very happy with Stephen's growth and contributions at Simulab over the past 11 years," states Christopher Toly, Founder and Chief Executive Officer of Simulab. "The team could not be more proud to...

Read more

San Diego-Based Alcohol and Drug Rehab Facility Helps Patients Restore Dignity During the Addiction Recovery Process

December 2, 2024 9:00 AM

Many people don't realize that restoring one's dignity is an important aspect of mental health, especially when it comes to recovering from addiction. Addiction is a complex disease with the commonality of triggering shame and creating a loss of dignity, with pain and suffering often being the root cause. This is why Shoreline Recovery Center is putting a larger focus on patient dignity."Having dignity is about feeling valued and respected for...

Read more

Bausch Health Appoints New Chief Medical Officer and Head of R&D

December 2, 2024 8:00 AM

LAVAL, QC / ACCESSWIRE / December 2, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce the appointment of Jonathan Sadeh M.D., M.Sc as Executive Vice President, Chief Medical Officer and Head of R&D. This strategic addition to our leadership team underscores our commitment to innovation, excellence, and enriching lives.Jonathan brings a wealth of experience and a proven track record of success both as a...

Read more

Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

December 2, 2024 8:00 AM

FORT LAUDERDALE, FL / ACCESSWIRE / December 2, 2024 / Sunshine Biopharma Inc. (NASDAQ:"SBFM") (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has completed mouse model studies providing proof-of-concept for the Company's K1.1 mRNA product as a novel therapeutic agent for human hepatocellular carcinoma.Human...

Read more

Park Mental Health Treatment Builds an Environment of Trust and Safety to Restore Dignity, Encourage Hope and Promote Healing for Clients

December 2, 2024 7:00 AM

When it comes to mental health, possessing dignity is critical to holistic wellness. Relating to a person's sense of self-worth, respect, and value, is foundational for each person's success. This is why Park Mental Health is promoting a focus on patient dignity.The universal concept of "dignity" is the state of being worthy of honor or respect. Yet, there are so many living without it.A person's dignity can become easily undermined in many...

Read more

Calcium Oxalate Labs, Inc. Introduces VELOXATM: Very Low Oxalate Teas for a Healthier Lifestyle*

December 2, 2024 6:00 AM

Calcium Oxalate Labs, Inc., the proud maker of Kidney C.O.P. Calcium Oxalate Protector, is excited to announce the launch of VELOXA®, a line of Very Low Oxalate Teas. These specially crafted, proprietary tea blends cater to individuals managing their oxalate intake who want to enjoy a flavorful cup of tea.VELOXA® Devine Cranberry Low Oxalate EnchinaceaCarton of 30 Pyramid Tea Bags TEAS LOW IN OXALATE AND TASTE GREAT!Until now, enjoying tea...

Read more